Login to Your Account

Merck Gets Closer to Biotech Innovation via Flagship Deal

By Jennifer Boggs
Managing Editor

Wednesday, April 11, 2012
A venture capital firm with a reputation for supporting early stage innovation, Flagship Ventures is teaming up with Merck & Co. Inc. in an unusual partnership that brings Merck closer to early stage discoveries while allowing young companies the chance to tap into the big pharma's expertise.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription